...
首页> 外文期刊>Cytotechnology >Xeno-free proliferation of human bone marrow mesenchymal stem cells
【24h】

Xeno-free proliferation of human bone marrow mesenchymal stem cells

机译:人骨髓间充质干细胞无异种增殖

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The proliferation of human bone marrow mesenchymal stem cells (MSCs) employing xeno-free materials not containing fetal calf serum (FCS) and porcine trypsin was investigated for the regenerative medicine of cartilage using MSCs. Four sequential subcultivations of MSCs using a medium containing 10% FCS and recombinant trypsin (TrypLESelect?) resulted in cell growth comparable to that with porcine trypsin. There was no apparent difference in the cell growth and morphology between two kinds of MSC stored in liquid nitrogen using 10% FCS plus DMSO or serum-free TC protector?. MSCs were isolated from human bone marrow cells, stored in liquid nitrogen, and sequentially subcultivated four times employing conventional materials that included FCS, porcine trypsin, and DMSO, or xeno-free materials that included serum-free medium (MesenCult-XF?), TC protector? and TrypLESelect?. Cells in the culture using the xeno-free materials maintained typical fibroblast-like morphology and grew more rapidly than the cells in the culture using the conventional materials, while the cell surface markers of MSCs (CD90 and CD166) were well maintained in both cultures. Chondrogenic pellet cultures were carried out using these subcultivated cells and a medium containing TGFβ3 and IGF1. The pellet culture using cells grown with the xeno-free materials showed an apparently higher gene expression of aggrecan, a chondrocyte marker, than the pellet culture using cells grown with the conventional materials. Consequently, MSCs that are isolated, stored, and grown using the xeno-free materials including the serum-free medium (MesenCult-XF?), TC protector?, and recombinant trypsin (TrypLESelect?) might be applicable for regenerative medicine of cartilage.
机译:研究了使用不含胎牛血清(FCS)和猪胰蛋白酶的无异种材料的人骨髓间充质干细胞(MSC)的增殖,以用于使用MSC的软骨再生药物。使用含有10%FCS和重组胰蛋白酶(TrypLESelect?)的培养基对MSC进行四个连续的亚培养,其细胞生长与猪胰蛋白酶相当。使用10%FCS加DMSO或无血清TC保护剂保存在液氮中的两种MSC的细胞生长和形态没有明显差异。从人骨髓细胞中分离出MSC,并将其储存在液氮中,并使用包括FCS,猪胰蛋白酶和DMSO在内的常规材料,或包括无血清培养基(MesenCult-XF?)的无异种材料,依次进行四次传代培养, TC保护器?和TrypLESelect?。使用不含异种材料的培养物中的细胞保持典型的成纤维细胞样形态,并且比使用常规材料的培养物中的细胞生长更快,而两种培养物中的MSCs(CD90和CD166)的细胞表面标记均保持良好。使用这些继代培养细胞和含有TGFβ3和IGF1的培养基进行软骨沉淀培养。使用不含异种材料的细胞培养的颗粒培养物,比使用传统材料生长的细胞的沉淀培养物,软骨细胞标记物聚集蛋白聚糖的基因表达明显更高。因此,使用包括无血清培养基(MesenCult-XF?),TC保护剂?和重组胰蛋白酶(TrypLESelect?)在内的无异种材料分离,储存和生长的MSC可能适用于软骨再生医学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号